Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
The author argues that attributing exercise hyperpnoea and dyspnea in heart failure patients solely to muscle mechano/metaboreflex and central command is an oversimplification that ignores other critical afferent pathways.
In their Exchange of Views, White and Bruce (2020) present and defend the idea that the muscle mechano/metaboreflex plays a significant role in exercise hyperpnoea, in synergy with the central chemoreflex. By manipulating these mechanisms, they propose to improve the shortness of breath experienced by cardiac patients, for instance. Multifarious data, including the response to static contractions, training, vascular occlusions (one-leg) or CO2 inhalation, were used by the authors to make their point. The main issue with the argumentation developed by the authors is that they appear to offer in their premises the conjecture they attempt to test as if it were a well-accepted, valid theory. Let me try to clarify this essential point: it is inexact to present the view, as a universally established proposition, that the ventilatory response to exercise can be accounted for by a balance between (i) a ‘central’ command, which has, to date, never been characterized in humans, and (ii) a stimulation of muscle afferent fibres. Many inputs (chemical, circulatory, thermal, etc.) capable of regulating breathing during exercise, along with some of the still mysterious characteristics of the systems that filter or select information while elaborating the ventilatory response, cannot be ignored. Consequently, by limiting the potential mechanisms to a balance between muscular and ‘central’ factors, any changes in breathing (produced by a vascular occlusion or by training, for instance) will be explainable only through one of these two mechanisms, or their interaction. Presentation of a breathing control system limited to two elements that are totally disconnected from the metabolic rate, and then interpreting any data accordingly, can only lead to ‘begging the question’. As a thought experiment, one could pick the old, yet elegant, theory of Harrison, Harrison, Calhoun, & Marsh (1932) on the role of afferent fibres originating in the right circulation that respond to the load imposed on venous return, a mechanism that has never been disproved (Haouzi, 2009). It is perfectly possible to explain the hyperventilation produced by exercise in patients with cardiac failure through such a mechanism. The beneficial effect of optimizing the medical treatment of cardiac failure to improve dyspnoea could also be rationalised very simply using this theory. It is unfair to use the established effects of the muscle mechano/metaboreceptors on blood pressure (or on blood flow redistribution) (Mitchell, 1990) as evidence for their role in the control of breathing. This certainly remains to be shown. It is undeniable that the stimulation of muscle nerve endings increases breathing, but so do most afferent fibres in the rest of the body that have synaptic connections inside the medulla and can be involved during muscular exercise (from the arterial chemoreceptors and baroreceptors to the receptors in the right or left heart, the small and large vessels, etc.). Of note, a mechanism based on vascular distension in the muscles, which uses the same afferent system as the muscle metaboreception (Haouzi, Chenuel, & Huszczuk, 2004), will produce a very different effect on breathing. Breathing will increase as blood flow increases or when venous return from the exercising muscles is impeded in the former, whereas breathing should be stimulated when blood flow decreases to levels that might not be even compatible with maintaining muscle contractions in the latter. Given that the response to dynamic exercise consists of an increase in muscle blood flow (an observation that remains true even in patients with cardiac failure, who, by definition, experience an increased load on venous return when exercising), why choose as a premise that muscle mechano/metaboreception would be the main relevant sensing mechanism involved in the shortness of breath in these patients? Finally, a model that implicates central CO2 chemoreception, even as a synergic mechanism, must be reconciled with the expected medullary alkalosis present in deconditioned patients with mild to moderate cardiac failure. The number and variety of inputs capable of stimulating breathing during exercise along with the still mysterious role played by the CNS in shaping the ventilatory response prevent us from fully appreciating and understanding the mechanisms implicated in this regulation. A causal oversimplification can be convenient and even useful for didactic purposes or to render a paper or a grant proposal easier to follow to a reader unfamiliar with the subject, but this approach can only provide an incorrect view of this complex topic. Causal reductionism certainly does not give justice to the exuberant creativity and intricate debates offered by a century-old worldwide literature on the control of breathing in health and disease (Dejours, 1963; Dejours, Raynaud, & Flandrois, 1959; Eldridge, 1994; Forster, Haouzi, & Dempsey, 2012; Grodins, 1950; Kao, 1956; Pflüger, 1868; Poon, 1993; Rylant, 1942; Whipp, Ward, Lamarra, Davis, & Wasserman, 1982; Zuntz & Geppert, 1886; and much more). More importantly, limiting our interpretation to mechanisms, which exact contribution remains to be established, certainly prevents the development of new and, hopefully, useful ways of understanding this surprisingly complex regulatory system, for which no convincing mechanism of control is currently available. None. Sole author.
No takes yet. Share an insight, caveat, or question.
Philippe Haouzi (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: